 |
Top 22 medical and healthcare startups in Denmark
Updated: May 02, 2024 | Editor: Jason Kwon |
1
Funding: $721.3M
Transmedics is a medical device company involved in the design and production of transplant devices.
Transmedics is a medical device company involved in the design and production of transplant devices.
2
Funding: $215.5M
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
Minervax is a biotechnology company developing a novel vaccine against Group B Streptococcus.
3
Funding: $204.3M
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer.
4
Funding: $190M
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
5
Funding: $190M
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
Hemab is focused on the development of bispecific antibodies for the treatment of rare bleeding disorders.
6
Funding: $175M
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines.
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines.
7
Funding: €151M
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders. Research by the founders working on the neuromuscular junction identified an approach that has not previously been exploited but shows great promise.
8
Funding: $160.4M
Galecto develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.
Galecto develops galectin modulators for the treatment of severe diseases, including fibrosis and cancer. The company builds on more than 10 years of research into galectins and galectin modulators, which combined with a strong patent estate gives Galecto Biotech a unique platform.
9
Funding: $97.3M
ADCendo is dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
ADCendo is dedicated to developing antibody-drug conjugates (ADCs) for treatment of cancer. We are taking the ADC approach to new levels through a focus on cancer-associated targets that are professional internalizers and allow for superior selectivity via highly preferential cancer expression.
10
Funding: $89.4M
Corti is a machine learning company that helps emergency departments to detect critical illnesses like cardiac arrest in real-time.
Corti is a machine learning company that helps emergency departments to detect critical illnesses like cardiac arrest in real-time.
11
Funding: $77.9M
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases
Muna develops transformative therapeutics to preserve brain function and enhance resilience to neurodegenerative diseases
12
Funding: $60.2M
SNIPR Biome is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota.
SNIPR Biome is to develop CRISPR-based medicines that give hope for effective and safe treatment of difficult-to-treat diseases in the future.Precision killing of bacteria has the impact to revolutionise the management of untreatable and difficult-to-treat infections as well as complex diseases directly impacted by the human microbiota.
13
Funding: €50M
Lenus eHealth is a B2B technology and innovation firm providing cloud-based SaaS to a broad variety of health professionals.
Lenus eHealth is a B2B technology and innovation firm providing cloud-based SaaS to a broad variety of health professionals.
14
Funding: $52.3M
MedTrace provides 15O water for positron emission tomography (PET) imaging. The startup’s platform consists of an automated hardware system for producing, dosing, and injecting 15O water and analytical software for image processing.
MedTrace provides 15O water for positron emission tomography (PET) imaging. The startup’s platform consists of an automated hardware system for producing, dosing, and injecting 15O water and analytical software for image processing.
15
Funding: $43.5M
Liva’s digital coaching platform provides scalable lifestyle change, disease management & patient engagement for NHS England, AXA PPP & more
Liva’s digital coaching platform provides scalable lifestyle change, disease management & patient engagement for NHS England, AXA PPP & more
16
Funding: $27M
In many conventional hygiene products found traces of synthetic fabrics such as bleach, chemical residues, perfume, cellulose, plastic,
In many conventional hygiene products found traces of synthetic fabrics such as bleach, chemical residues, perfume, cellulose, plastic,
17
Funding: $12M
Nøie is customised skincare based on individual skin profiles, scientifically proven ingredients, and shared knowledge within a community united by similar issues. Our algorithms harness the power of the crowd to help the individual.
Nøie is customised skincare based on individual skin profiles, scientifically proven ingredients, and shared knowledge within a community united by similar issues. Our algorithms harness the power of the crowd to help the individual.
18
Funding: $6.5M
Motosumo is unlocking that potential using our background in professional sports analysis.
Motosumo is unlocking that potential using our background in professional sports analysis.
19
Funding: $5.2M
Radiobotics are developing stellar machine learning algorithms, supporting doctors in analysing medical images.
Radiobotics are developing stellar machine learning algorithms, supporting doctors in analysing medical images.
20
Funding: $975.5K
TeleSkin is a high-tech venture making hardware and software for the early detection of skin cancer, melanoma, and other skin conditions. Using breakthrough imaging and services techniques, we offer a comprehensive end-to-end solution for the analysis of moles, lesions, and other skin conditions via a combination of dermascopy, spectroscopy, and other cutting edge techniques.
TeleSkin is a high-tech venture making hardware and software for the early detection of skin cancer, melanoma, and other skin conditions. Using breakthrough imaging and services techniques, we offer a comprehensive end-to-end solution for the analysis of moles, lesions, and other skin conditions via a combination of dermascopy, spectroscopy, and other cutting edge techniques.
22
Sonohaler is a digital health company that empowers people with asthma live an active and healthy life.
